Case Report: Exome Sequencing Identified a Novel Compound Heterozygous Variation in

Bruck syndrome type 2 PLOD2 gene immunohistochemistry detection osteogenesis imperfecta whole-exome sequencing

Journal

Frontiers in genetics
ISSN: 1664-8021
Titre abrégé: Front Genet
Pays: Switzerland
ID NLM: 101560621

Informations de publication

Date de publication:
2021
Historique:
received: 21 10 2020
accepted: 28 01 2021
entrez: 5 3 2021
pubmed: 6 3 2021
medline: 6 3 2021
Statut: epublish

Résumé

Bruck Syndrome (BRKS) is a rare type of recessive osteogenesis imperfecta (OI) and consists of two subtypes, BRKS1 and BRKS2, which are caused by variations in

Identifiants

pubmed: 33664768
doi: 10.3389/fgene.2021.619948
pmc: PMC7921790
doi:

Types de publication

Case Reports

Langues

eng

Pagination

619948

Informations de copyright

Copyright © 2021 Zhang, Hu, Mu, Yu, Chen, Mi, Yang and Guo.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Clin Endocrinol Metab. 2013 Aug;98(8):3095-103
pubmed: 23771926
Nat Commun. 2018 Feb 06;9(1):512
pubmed: 29410444
J Biol Chem. 2003 Oct 17;278(42):40967-72
pubmed: 12881513
Biochim Biophys Acta. 2005 Jun 30;1741(1-2):95-102
pubmed: 15955452
Hum Mol Genet. 2014 Sep 15;23(18):4822-31
pubmed: 24777781
J Bone Miner Res. 2018 Jul;33(7):1377-1378
pubmed: 29878396
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Biomed Res Int. 2019 May 14;2019:2492590
pubmed: 31218223
Clin Genet. 1989 Aug;36(2):122-6
pubmed: 2766569
Sci Rep. 2017 Apr 05;7:46021
pubmed: 28378777
J Biol Chem. 1997 Mar 14;272(11):6831-4
pubmed: 9054364
Osteoporos Int. 2017 Oct;28(10):2985-2995
pubmed: 28725987
J Cancer. 2020 Mar 13;11(12):3467-3475
pubmed: 32284742
Calcif Tissue Int. 2018 Mar;102(3):296-309
pubmed: 29177700
Endocr Dev. 2015;28:259-76
pubmed: 26138847
J Bone Miner Res. 2018 Apr;33(4):753-760
pubmed: 29178448
Calcif Tissue Int. 2013 Oct;93(4):338-47
pubmed: 23508630
Diagn Pathol. 2019 Jul 13;14(1):76
pubmed: 31299979
Bone. 2020 Jan;130:115047
pubmed: 31472299
Am J Hum Genet. 2010 Apr 9;86(4):551-9
pubmed: 20362275
Proc Natl Acad Sci U S A. 1999 Feb 2;96(3):1054-8
pubmed: 9927692
Crit Rev Biochem Mol Biol. 2017 Feb;52(1):74-95
pubmed: 28006962
Mol Biol Cell. 2000 Nov;11(11):3925-35
pubmed: 11071917
Birth Defects Res A Clin Mol Teratol. 2009 Oct;85(10):811-21
pubmed: 19637253
Lancet. 2016 Apr 16;387(10028):1657-71
pubmed: 26542481
Prenat Diagn. 2018 Aug;38(9):692-699
pubmed: 29907962

Auteurs

Jing Zhang (J)

Prenatal Diagnosis Center, Shijiazhuang Obstetrics and Gynecology Hospital, Shijiazhuang, China.

Huaying Hu (H)

School of Medicine, Xiamen University, Xiamen, China.
Jiaen Genetics Laboratory, Beijing Jiaen Hospital, Beijing, China.

Weihong Mu (W)

Prenatal Diagnosis Center, Shijiazhuang Obstetrics and Gynecology Hospital, Shijiazhuang, China.

Mei Yu (M)

Prenatal Diagnosis Center, Shijiazhuang Obstetrics and Gynecology Hospital, Shijiazhuang, China.

Wenqi Chen (W)

Prenatal Diagnosis Center, Shijiazhuang Obstetrics and Gynecology Hospital, Shijiazhuang, China.

Dongqing Mi (D)

Prenatal Diagnosis Center, Shijiazhuang Obstetrics and Gynecology Hospital, Shijiazhuang, China.

Kai Yang (K)

Prenatal Diagnosis Center, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China.

Qing Guo (Q)

Prenatal Diagnosis Center, Shijiazhuang Obstetrics and Gynecology Hospital, Shijiazhuang, China.

Classifications MeSH